{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-030043","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2023-04-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.753629+00:00","generated_at":"2026-06-17T01:17:52.150511+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CorMedix appoints Robert Stewart to Board of Directors","bullets":["Robert Stewart appointed to Board effective April 13, 2023; Board now has 8 directors, 7 independent.","Stewart is CEO of Theramex; former CEO of Amneal Pharma and COO of Allergan.","Received initial option for 25,000 shares (1/3 vesting at grant, then annually); additional prorated option for 14,200 shares.","Stewart's experience expected to aid CorMedix's transition from development to commercial phase, per CEO.","Press release highlights commercial potential for lead product DefenCath."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-030043","json":"https://secwatch.observer/filing/0001213900-23-030043.json","markdown":"https://secwatch.observer/filing/0001213900-23-030043.md","text":"https://secwatch.observer/filing/0001213900-23-030043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/0001213900-23-030043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/ea177005-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T01:17:52.150511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"68acbd7960","claim":"Robert Stewart was appointed as Director at CorMedix Inc..","evidence_excerpt":"On April 13, 2023, the Board of Directors (the “Board”) of CorMedix Inc. (the “Company”) appointed Robert Stewart as a director, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1410098/000121390023030043/0001213900-23-030043-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}